longtext: 3G8Y-pdb

content
HEADER    HYDROLASE                               12-FEB-09   3G8Y
TITLE     CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE (BVU_4111) FROM BACTEROIDES
TITLE    2 VULGATUS ATCC 8482 AT 1.90 A RESOLUTION
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: SUSD/RAGB-ASSOCIATED ESTERASE-LIKE PROTEIN;
COMPND   3 CHAIN: A;
COMPND   4 FRAGMENT: UNP RESIDUES 25-414;
COMPND   5 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: BACTEROIDES VULGATUS ATCC 8482;
SOURCE   3 ORGANISM_TAXID: 435590;
SOURCE   4 STRAIN: DSM 1447 / NCTC 11154;
SOURCE   5 ATCC: 8482;
SOURCE   6 GENE: YP_001301335.1, BVU_4111;
SOURCE   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE   9 EXPRESSION_SYSTEM_STRAIN: HK100;
SOURCE  10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE  11 EXPRESSION_SYSTEM_PLASMID: SPEEDET
KEYWDS    SUSD/RAGB-ASSOCIATED ESTERASE-LIKE PROTEIN, STRUCTURAL GENOMICS,
KEYWDS   2 JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE
KEYWDS   3 INITIATIVE, PSI-2, HYDROLASE
EXPDTA    X-RAY DIFFRACTION
AUTHOR    JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG)
REVDAT   2   28-JUL-10 3G8Y    1       HEADER TITLE  KEYWDS
REVDAT   1   24-FEB-09 3G8Y    0
JRNL        AUTH   JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG)
JRNL        TITL   CRYSTAL STRUCTURE OF SUSD/RAGB-ASSOCIATED ESTERASE-LIKE
JRNL        TITL 2 PROTEIN (YP_001301335.1) FROM BACTEROIDES VULGATUS ATCC 8482
JRNL        TITL 3 AT 1.90 A RESOLUTION
JRNL        REF    TO BE PUBLISHED
JRNL        REFN
REMARK   2
REMARK   2 RESOLUTION.    1.90 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : REFMAC 5.2.0019
REMARK   3   AUTHORS     : MURSHUDOV,VAGIN,DODSON
REMARK   3
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 29.40
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000
REMARK   3   COMPLETENESS FOR RANGE        (%) : 100.0
REMARK   3   NUMBER OF REFLECTIONS             : 44778
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.170
REMARK   3   R VALUE            (WORKING SET) : 0.168
REMARK   3   FREE R VALUE                     : 0.209
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.000
REMARK   3   FREE R VALUE TEST SET COUNT      : 2257
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 20
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.90
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 1.95
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 3023
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 100.00
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2260
REMARK   3   BIN FREE R VALUE SET COUNT          : 170
REMARK   3   BIN FREE R VALUE                    : 0.3240
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 3106
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 55
REMARK   3   SOLVENT ATOMS            : 471
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 18.61
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 25.72
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : 0.38000
REMARK   3    B22 (A**2) : 0.38000
REMARK   3    B33 (A**2) : -0.57000
REMARK   3    B12 (A**2) : 0.19000
REMARK   3    B13 (A**2) : 0.00000
REMARK   3    B23 (A**2) : 0.00000
REMARK   3
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.
REMARK   3   ESU BASED ON R VALUE                            (A): 0.119
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.120
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.082
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.810
REMARK   3
REMARK   3 CORRELATION COEFFICIENTS.
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.959
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.940
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  3330 ; 0.013 ; 0.022
REMARK   3   BOND LENGTHS OTHERS               (A):  2296 ; 0.002 ; 0.020
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  4511 ; 1.544 ; 1.963
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  5583 ; 1.025 ; 3.000
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   410 ; 4.004 ; 5.000
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   147 ;30.751 ;23.946
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):   537 ;11.594 ;15.000
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    17 ; 9.954 ;15.000
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   475 ; 0.082 ; 0.200
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  3711 ; 0.006 ; 0.020
REMARK   3   GENERAL PLANES OTHERS             (A):   685 ; 0.002 ; 0.020
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):   711 ; 0.210 ; 0.300
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  2376 ; 0.178 ; 0.300
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  1644 ; 0.187 ; 0.500
REMARK   3   NON-BONDED TORSION OTHERS         (A):  1531 ; 0.088 ; 0.500
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):   581 ; 0.197 ; 0.500
REMARK   3   H-BOND (X...Y) OTHERS             (A):     1 ; 0.205 ; 0.500
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):    14 ; 0.152 ; 0.300
REMARK   3   SYMMETRY VDW OTHERS               (A):    71 ; 0.260 ; 0.300
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):    52 ; 0.188 ; 0.500
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  2173 ; 1.861 ; 3.000
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):   804 ; 0.453 ; 3.000
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  3273 ; 2.602 ; 5.000
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  1481 ; 4.002 ; 8.000
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  1238 ; 4.814 ;11.000
REMARK   3
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3  NCS RESTRAINTS STATISTICS
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK   3
REMARK   3  TLS DETAILS
REMARK   3   NUMBER OF TLS GROUPS  : NULL
REMARK   3
REMARK   3  BULK SOLVENT MODELLING.
REMARK   3   METHOD USED : BABINET MODEL WITH MASK
REMARK   3   PARAMETERS FOR MASK CALCULATION
REMARK   3   VDW PROBE RADIUS   : 1.20
REMARK   3   ION PROBE RADIUS   : 0.80
REMARK   3   SHRINKAGE RADIUS   : 0.80
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE
REMARK   3  RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR
REMARK   3  SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE
REMARK   3  OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75
REMARK   3  TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET
REMARK   3  INCORPORATION. 3. PEG MOLECULES FROM CRYSTALLIZATION AND ETHYLENE
REMARK   3  GLYCOL FROM CRYOPROTECTION ARE MODELED IN THIS STRUCTURE. 4.
REMARK   3  UNKNOWN ELECTRON DENSITY IS OBSERVED AND UNMODELED NEAR SER 256
REMARK   3  AND HIS 398.
REMARK   4
REMARK   4 3G8Y COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-09.
REMARK 100 THE RCSB ID CODE IS RCSB051572.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 07-DEC-08
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : 9.0
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : SSRL
REMARK 200  BEAMLINE                       : BL9-2
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.91162, 0.97982, 0.97966
REMARK 200  MONOCHROMATOR                  : DOUBLE CRYSTAL
REMARK 200  OPTICS                         : FLAT COLLIMATING MIRROR, TOROID
REMARK 200                                   FOCUSING MIRROR
REMARK 200
REMARK 200  DETECTOR TYPE                  : CCD
REMARK 200  DETECTOR MANUFACTURER          : MARMOSAIC 325 MM CCD
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200  DATA SCALING SOFTWARE          : SCALA
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 44914
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.900
REMARK 200  RESOLUTION RANGE LOW       (A) : 29.399
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 100.0
REMARK 200  DATA REDUNDANCY                : 7.100
REMARK 200  R MERGE                    (I) : 0.14300
REMARK 200  R SYM                      (I) : 0.14300
REMARK 200   FOR THE DATA SET  : 4.8240
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.95
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0
REMARK 200  DATA REDUNDANCY IN SHELL       : 7.20
REMARK 200  R MERGE FOR SHELL          (I) : 0.77800
REMARK 200  R SYM FOR SHELL            (I) : 0.77800
REMARK 200   FOR SHELL         : 1.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: MAD
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD
REMARK 200 SOFTWARE USED: SHELXD, AUTOSHARP
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 58.61
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 20.0% PEG 6000, 0.1M BICINE
REMARK 280  PH 9.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -Y,X-Y,Z+1/3
REMARK 290       3555   -X+Y,-X,Z+2/3
REMARK 290       4555   -X,-Y,Z+1/2
REMARK 290       5555   Y,-X+Y,Z+5/6
REMARK 290       6555   X-Y,X,Z+1/6
REMARK 290       7555   Y,X,-Z+1/3
REMARK 290       8555   X-Y,-Y,-Z
REMARK 290       9555   -X,-X+Y,-Z+2/3
REMARK 290      10555   -Y,-X,-Z+5/6
REMARK 290      11555   -X+Y,Y,-Z+1/2
REMARK 290      12555   X,X-Y,-Z+1/6
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000      107.79533
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000      215.59067
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   4  0.000000  0.000000  1.000000      161.69300
REMARK 290   SMTRY1   5  0.500000  0.866025  0.000000        0.00000
REMARK 290   SMTRY2   5 -0.866025  0.500000  0.000000        0.00000
REMARK 290   SMTRY3   5  0.000000  0.000000  1.000000      269.48833
REMARK 290   SMTRY1   6  0.500000 -0.866025  0.000000        0.00000
REMARK 290   SMTRY2   6  0.866025  0.500000  0.000000        0.00000
REMARK 290   SMTRY3   6  0.000000  0.000000  1.000000       53.89767
REMARK 290   SMTRY1   7 -0.500000  0.866025  0.000000        0.00000
REMARK 290   SMTRY2   7  0.866025  0.500000  0.000000        0.00000
REMARK 290   SMTRY3   7  0.000000  0.000000 -1.000000      107.79533
REMARK 290   SMTRY1   8  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   8  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   8  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   9 -0.500000 -0.866025  0.000000        0.00000
REMARK 290   SMTRY2   9 -0.866025  0.500000  0.000000        0.00000
REMARK 290   SMTRY3   9  0.000000  0.000000 -1.000000      215.59067
REMARK 290   SMTRY1  10  0.500000 -0.866025  0.000000        0.00000
REMARK 290   SMTRY2  10 -0.866025 -0.500000  0.000000        0.00000
REMARK 290   SMTRY3  10  0.000000  0.000000 -1.000000      269.48833
REMARK 290   SMTRY1  11 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2  11  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3  11  0.000000  0.000000 -1.000000      161.69300
REMARK 290   SMTRY1  12  0.500000  0.866025  0.000000        0.00000
REMARK 290   SMTRY2  12  0.866025 -0.500000  0.000000        0.00000
REMARK 290   SMTRY3  12  0.000000  0.000000 -1.000000       53.89767
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE RESULTS FROM SIZE EXCLUSION CHROMATOGRAPHY SUPPORT THE
REMARK 300 ASSIGNMENT OF A DIMER AS A SIGNIFICANT OLIGOMERIZATION STATE.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 6450 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 30320 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.7 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 350   BIOMT1   2  0.500000  0.866025  0.000000      -37.95150
REMARK 350   BIOMT2   2  0.866025 -0.500000  0.000000       65.73393
REMARK 350   BIOMT3   2  0.000000  0.000000 -1.000000       53.89767
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470   M RES CSSEQI  ATOMS
REMARK 470     ARG A  63    CG   CD   NE   CZ   NH1  NH2
REMARK 470     GLN A  69    CD   OE1  NE2
REMARK 470     GLU A  90    CG   CD   OE1  OE2
REMARK 470     LYS A  92    CG   CD   CE   NZ
REMARK 470     LYS A 104    CG   CD   CE   NZ
REMARK 470     GLU A 106    CG   CD   OE1  OE2
REMARK 470     LYS A 134    CG   CD   CE   NZ
REMARK 470     ASP A 161    OD1  OD2
REMARK 470     LYS A 270    CD   CE   NZ
REMARK 470     LYS A 296    CG   CD   CE   NZ
REMARK 470     ARG A 315    CZ   NH1  NH2
REMARK 470     LYS A 373    NZ
REMARK 470     ARG A 410    NH1  NH2
REMARK 470     LYS A 414    CD   CE   NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    ARG A  93      123.28    -36.02
REMARK 500    LYS A 134      -99.67    -93.11
REMARK 500    ALA A 192       -4.03     83.82
REMARK 500    ASP A 198      -93.57   -113.61
REMARK 500    ASP A 203      -70.34   -162.79
REMARK 500    TRP A 222     -157.95   -108.38
REMARK 500    SER A 256     -126.83     56.29
REMARK 500    GLU A 335       42.93   -141.32
REMARK 500    ASN A 392       42.26     70.14
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CHIRAL CENTERS
REMARK 500
REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL
REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY
REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR
REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE
REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16)
REMARK 500
REMARK 500  M RES CSSEQI    IMPROPER   EXPECTED   FOUND DETAILS
REMARK 500    ARG A  93        24.8      L          L   OUTSIDE RANGE
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 2
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 3
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 4
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 5
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 6
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 7
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 8
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 9
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 10
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 11
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 12
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 13
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 393239   RELATED DB: TARGETDB
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG
REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE
REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
REMARK 999 THE CLONED CONSTRUCT CONTAINS RESIDUES 25-414 OF THE FULL
REMARK 999 LENGTH PROTEIN.
DBREF  3G8Y A   25   414  UNP    A6L7P9   A6L7P9_BACV8    25    414
SEQADV 3G8Y GLY A    0  UNP  A6L7P9              LEADER SEQUENCE
SEQRES   1 A  391  GLY TYR GLN PRO GLU LYS HIS ALA VAL VAL LYS SER ASP
SEQRES   2 A  391  ARG GLY ASP GLY ARG LEU LEU SER THR TYR ALA ILE VAL
SEQRES   3 A  391  HIS GLU MSE LEU LYS ASP THR HIS PRO GLN TYR ALA TYR
SEQRES   4 A  391  ARG SER GLY MSE SER ALA GLN GLU PHE THR GLN TRP GLN
SEQRES   5 A  391  ASP GLY VAL ARG ALA ALA MSE VAL GLU ILE MSE LYS PHE
SEQRES   6 A  391  PRO GLU ILE LYS ARG GLN PRO SER PRO VAL CYS VAL LYS
SEQRES   7 A  391  THR GLU LYS LYS GLU GLY TYR ILE LEU GLU LYS TRP GLU
SEQRES   8 A  391  PHE TYR PRO PHE PRO LYS SER VAL SER THR PHE LEU VAL
SEQRES   9 A  391  LEU LYS PRO GLU HIS LEU LYS GLY ALA VAL PRO GLY VAL
SEQRES  10 A  391  LEU CYS ILE PRO GLY SER GLY ARG THR LYS GLU GLY LEU
SEQRES  11 A  391  VAL GLY GLU PRO GLY ILE CYS ASP LYS LEU THR GLU ASP
SEQRES  12 A  391  TYR ASN ASN PRO LYS VAL SER MSE ALA LEU ASN MSE VAL
SEQRES  13 A  391  LYS GLU GLY TYR VAL ALA VAL ALA VAL ASP ASN ALA ALA
SEQRES  14 A  391  ALA GLY GLU ALA SER ASP LEU GLU CYS TYR ASP LYS GLY
SEQRES  15 A  391  TRP ASN TYR ASP TYR ASP VAL VAL SER ARG PHE LEU LEU
SEQRES  16 A  391  GLU LEU GLY TRP SER TRP LEU GLY TYR THR SER TYR LEU
SEQRES  17 A  391  ASP MSE GLN VAL LEU ASN TRP MSE LYS ALA GLN SER TYR
SEQRES  18 A  391  ILE ARG LYS ASP ARG ILE VAL ILE SER GLY PHE SER LEU
SEQRES  19 A  391  GLY THR GLU PRO MSE MSE VAL LEU GLY VAL LEU ASP LYS
SEQRES  20 A  391  ASP ILE TYR ALA PHE VAL TYR ASN ASP PHE LEU CYS GLN
SEQRES  21 A  391  THR GLN GLU ARG ALA VAL VAL MSE THR LYS PRO ASP LYS
SEQRES  22 A  391  GLU ASN ARG ARG PRO PHE PRO ASN SER ILE ARG HIS LEU
SEQRES  23 A  391  ILE PRO GLY TYR TRP ARG TYR PHE ASN PHE PRO ASP VAL
SEQRES  24 A  391  VAL ALA SER LEU ALA PRO ARG PRO ILE ILE PHE THR GLU
SEQRES  25 A  391  GLY GLY LEU ASP ARG ASP PHE ARG LEU VAL GLN SER ALA
SEQRES  26 A  391  TYR ALA ALA SER GLY LYS PRO GLU ASN ALA GLU PHE HIS
SEQRES  27 A  391  HIS TYR PRO LYS PHE ALA ASP LYS ALA VAL ARG LYS ASP
SEQRES  28 A  391  VAL GLU HIS LEU ASP GLU GLY LEU ASP SER LYS THR TYR
SEQRES  29 A  391  PHE GLU ALA VAL ASN VAL ASP PRO PRO SER HIS TYR PHE
SEQRES  30 A  391  LYS ASN GLU LEU VAL ILE PRO TRP LEU ARG LYS VAL LEU
SEQRES  31 A  391  LYS
MODRES 3G8Y MSE A   52  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A   66  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A   82  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A   86  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A  174  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A  178  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A  233  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A  239  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A  262  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A  263  MET  SELENOMETHIONINE
MODRES 3G8Y MSE A  291  MET  SELENOMETHIONINE
HET    MSE  A  52       8
HET    MSE  A  66       8
HET    MSE  A  82       8
HET    MSE  A  86       8
HET    MSE  A 174       8
HET    MSE  A 178      16
HET    MSE  A 233       8
HET    MSE  A 239       8
HET    MSE  A 262      16
HET    MSE  A 263       8
HET    MSE  A 291      16
HET    EDO  A   1       4
HET    EDO  A   2       4
HET    EDO  A   3       4
HET    EDO  A   4       4
HET    EDO  A   5       4
HET    EDO  A   6       4
HET    EDO  A   7       4
HET    EDO  A   8       4
HET    EDO  A   9       4
HET    EDO  A  10       4
HET    EDO  A  11       4
HET    EDO  A  12       4
HET    PEG  A  13       7
HETNAM     MSE SELENOMETHIONINE
HETNAM     EDO 1,2-ETHANEDIOL
HETNAM     PEG DI(HYDROXYETHYL)ETHER
HETSYN     EDO ETHYLENE GLYCOL
FORMUL   1  MSE    11(C5 H11 N O2 SE)
FORMUL   2  EDO    12(C2 H6 O2)
FORMUL  14  PEG    C4 H10 O3
FORMUL  15  HOH   *471(H2 O)
HELIX    1   1 GLN A   26  ALA A   31  5                                   6
HELIX    2   2 SER A   44  ASP A   55  1                                  12
HELIX    3   3 SER A   67  LYS A   87  1                                  21
HELIX    4   4 THR A  149  VAL A  154  1                                   6
HELIX    5   5 CYS A  160  THR A  164  5                                   5
HELIX    6   6 SER A  173  LYS A  180  1                                   8
HELIX    7   7 ALA A  193  SER A  197  5                                   5
HELIX    8   8 LEU A  199  ASP A  203  5                                   5
HELIX    9   9 ASP A  209  LEU A  220  1                                  12
HELIX   10  10 SER A  223  ALA A  241  1                                  19
HELIX   11  11 GLY A  258  ASP A  269  1                                  12
HELIX   12  12 GLN A  283  MSE A  291  1                                   9
HELIX   13  13 SER A  305  LEU A  309  5                                   5
HELIX   14  14 GLY A  312  TYR A  316  5                                   5
HELIX   15  15 ASN A  318  SER A  325  1                                   8
HELIX   16  16 LEU A  338  SER A  352  1                                  15
HELIX   17  17 LYS A  354  GLU A  356  5                                   3
HELIX   18  18 TYR A  363  ALA A  367  5                                   5
HELIX   19  19 ASP A  368  ARG A  372  5                                   5
HELIX   20  20 ASP A  383  VAL A  391  1                                   9
HELIX   21  21 ASP A  394  HIS A  398  5                                   5
HELIX   22  22 LYS A  401  LEU A  413  1                                  13
SHEET    1   A 9 VAL A  98  LYS A 105  0
SHEET    2   A 9 TYR A 108  PHE A 115 -1  O  TYR A 108   N  LYS A 105
SHEET    3   A 9 SER A 123  PRO A 130 -1  O  VAL A 127   N  GLU A 111
SHEET    4   A 9 VAL A 184  ALA A 187 -1  O  ALA A 185   N  LEU A 128
SHEET    5   A 9 VAL A 137  ILE A 143  1  N  CYS A 142   O  VAL A 186
SHEET    6   A 9 ILE A 245  PHE A 255  1  O  ARG A 246   N  VAL A 137
SHEET    7   A 9 ALA A 274  ASN A 278  1  O  VAL A 276   N  GLY A 254
SHEET    8   A 9 ILE A 331  PHE A 333  1  O  ILE A 332   N  TYR A 277
SHEET    9   A 9 ALA A 358  PHE A 360  1  O  GLU A 359   N  ILE A 331
LINK         C   GLU A  51                 N   MSE A  52     1555   1555  1.33
LINK         C   MSE A  52                 N   LEU A  53     1555   1555  1.34
LINK         C   GLY A  65                 N   MSE A  66     1555   1555  1.33
LINK         C   MSE A  66                 N   SER A  67     1555   1555  1.33
LINK         C   ALA A  81                 N   MSE A  82     1555   1555  1.33
LINK         C   MSE A  82                 N   VAL A  83     1555   1555  1.33
LINK         C   ILE A  85                 N   MSE A  86     1555   1555  1.33
LINK         C   MSE A  86                 N   LYS A  87     1555   1555  1.33
LINK         C   SER A 173                 N   MSE A 174     1555   1555  1.33
LINK         C   MSE A 174                 N   ALA A 175     1555   1555  1.33
LINK         C   ASN A 177                 N  AMSE A 178     1555   1555  1.33
LINK         C   ASN A 177                 N  BMSE A 178     1555   1555  1.33
LINK         C  AMSE A 178                 N   VAL A 179     1555   1555  1.33
LINK         C  BMSE A 178                 N   VAL A 179     1555   1555  1.33
LINK         C   ASP A 232                 N   MSE A 233     1555   1555  1.33
LINK         C   MSE A 233                 N  AGLN A 234     1555   1555  1.33
LINK         C   MSE A 233                 N  BGLN A 234     1555   1555  1.34
LINK         C   TRP A 238                 N   MSE A 239     1555   1555  1.33
LINK         C   MSE A 239                 N   LYS A 240     1555   1555  1.33
LINK         C   PRO A 261                 N  AMSE A 262     1555   1555  1.33
LINK         C   PRO A 261                 N  BMSE A 262     1555   1555  1.34
LINK         C  AMSE A 262                 N   MSE A 263     1555   1555  1.33
LINK         C  BMSE A 262                 N   MSE A 263     1555   1555  1.34
LINK         C   MSE A 263                 N   VAL A 264     1555   1555  1.33
LINK         C   VAL A 290                 N  AMSE A 291     1555   1555  1.33
LINK         C   VAL A 290                 N  BMSE A 291     1555   1555  1.34
LINK         C  AMSE A 291                 N   THR A 292     1555   1555  1.34
LINK         C  BMSE A 291                 N   THR A 292     1555   1555  1.33
CISPEP   1 ALA A  327    PRO A  328          0         1.77
SITE     1 AC1  5 ARG A 343  ASP A 374  GLU A 376  LYS A 411
SITE     2 AC1  5 HOH A 803
SITE     1 AC2  4 ASP A 279  PHE A 280  PHE A 388  HIS A 398
SITE     1 AC3  6 MSE A  52  ASP A  55  PHE A 118  PRO A 119
SITE     2 AC3  6 HOH A 449  HOH A 656
SITE     1 AC4  5 GLY A 145  SER A 146  ARG A 148  PHE A 255
SITE     2 AC4  5 HOH A 788
SITE     1 AC5  7 ASP A 211  VAL A 212  ARG A 215  ILE A 306
SITE     2 AC5  7 HOH A 517  HOH A 523  HOH A 567
SITE     1 AC6  6 TYR A  60  GLY A  77  GLU A  84  TYR A 316
SITE     2 AC6  6 HOH A 851  HOH A 871
SITE     1 AC7  3 LYS A  87  LEU A 220  GLY A 221
SITE     1 AC8  7 PHE A 366  VAL A 371  LYS A 373  GLU A 389
SITE     2 AC8  7 HOH A 486  HOH A 630  HOH A 689
SITE     1 AC9  8 HOH A  21  THR A 284  HIS A 308  ILE A 310
SITE     2 AC9  8 TYR A 313  TRP A 314  HOH A 562  HOH A 591
SITE     1 BC1  6 TYR A  62  SER A  64  ARG A 343  LEU A 344
SITE     2 BC1  6 HOH A 554  HOH A 650
SITE     1 BC2  4 GLN A  26  GLY A 194  GLU A 195  HOH A 820
SITE     1 BC3  6 LYS A 369  ARG A 372  GLU A 403  PRO A 407
SITE     2 BC3  6 HOH A 599  HOH A 612
SITE     1 BC4  4 SER A 146  GLY A 147  ARG A 148  HOH A 657
CRYST1   75.903   75.903  323.386  90.00  90.00 120.00 P 61 2 2     12
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.013175  0.007606  0.000000        0.00000
SCALE2      0.000000  0.015213  0.000000        0.00000
SCALE3      0.000000  0.000000  0.003092        0.00000
TER    3191      LYS A 414
MASTER      405    0   24   22    9    0   22    6 3632    1  188   31
END